Shilpa Medicare Board Meeting on Nov 5 to Approve Q2 FY27 Results

Shilpa Medicare Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item is to consider and approve the unaudited financial results for the second quarter and half-year ended September 30, 2026, covering both consolidated and standalone figures. Additionally, the company has informed about the closure of its trading window from October 1, 2026, to November 7, 2026, in compliance with its insider trading code.